Bleichroeder LP Global Blood Therapeutics, Inc. Transaction History

Bleichroeder LP

  • $296 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$25.68 - $35.59 $3.21 Million - $4.45 Million
-125,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$25.48 - $37.34 $637,000 - $933,500
25,000 Added 25.0%
125,000 $3.19 Million
Q1 2021

May 17, 2021
BUY
$38.94 - $50.85 $3.89 Million - $5.09 Million
100,000 New
100,000 $4.08 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email